GlassScriptPhysician profile
Jose Manuel Reyes
NPI 1841455664
$27,000.38
in general payments reported to CMS, 2019-2025
48 companies · $5,320 in 2025
The $5,320 reported for 2025 was more than what 91% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $828 · 2020: $4,153 · 2021: $4,851 · 2022: $1,225 · 2023: $5,841 · 2024: $4,782 · 2025: $5,320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $3,550 · Travel and Lodging: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,850.00 |
| Food and Beverage | $3,549.66 |
| Travel and Lodging | $543.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $20,658.92 | 2019-2025 | General - Therapies, Moses 550 D\F\L, Lithovue |
| Abbvie INC. | $644.94 | 2019-2025 | |
| Procept Biorobotics Corporation | $572.50 | 2021-2025 | Aquabeam System, Aquabeam Robotic System |
| Janssen Biotech, INC. | $494.46 | 2019-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $476.77 | 2023-2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $353.80 | 2021-2025 | |
| Ferring Pharmaceuticals INC. | $326.72 | 2019-2025 | Adstiladrin |
| Pfizer INC. | $275.14 | 2019-2024 | |
| 180 Medical, INC. | $270.38 | 2019-2025 | Gentlecath, Gentlecath Glide |
| Tolmar, INC. | $262.08 | 2023-2025 | Jatenzo, Eligard |
| Progenics Pharmaceuticals, INC. | $213.71 | 2021-2024 | Pylarify |
| Bayer Healthcare Pharmaceuticals INC. | $209.41 | 2023-2025 | |
| Urovant Sciences INC | $184.42 | 2021-2022 | |
| Antares Pharma, INC. | $138.59 | 2020-2025 | Xyosted |
| Laborie Medical Technologies Corp. | $134.94 | 2020-2025 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agiliti Surgical, INC. | $133.03 | 2022-2023 | Trinity, Sonablate, Soltive |
| Accord Healthcare, INC. | $127.21 | 2024-2025 | |
| Intuitive Surgical, INC. | $125.86 | 2019 | |
| Dendreon Pharmaceuticals LLC | $106.98 | 2020-2025 | Provenge |
| Endo USA, INC. | $103.71 | 2024-2025 | Xiaflex, Aveed |
| Astellas Pharma US INC | $100.73 | 2019-2023 | Myrbetriq |
| Coloplast Corp | $96.64 | 2019-2021 | |
| Myriad Genetic Laboratories, INC. | $93.68 | 2021-2024 | Prolaris |
| Dentsply Ih Ab | $85.40 | 2025 | Lofric |
| Myovant Sciences INC. | $63.20 | 2021-2022 | |
| Teleflex LLC | $61.20 | 2022-2023 | Urolift |
| Endo Pharmaceuticals INC. | $61.10 | 2019-2023 | Xiaflex, Aveed |
| Acerus Pharmaceuticals Corporation | $57.98 | 2020-2022 | |
| Allergan, INC. | $51.88 | 2019-2021 | |
| Abc Home Medical Supply, INC. | $48.05 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $46.76 | 2024 | Bard Urinary Drainage Bag |
| Neotract INC. | $42.05 | 2019 | |
| Immunitybio, INC. | $41.10 | 2025 | |
| Innovation Technologies INC | $36.44 | 2021 | |
| Medtronic USA, INC. | $35.82 | 2019 | |
| Karl Storz Endoscopy-America | $31.61 | 2019 | |
| Halozyme INC | $25.00 | 2023 | |
| Convatec INC. | $24.79 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $23.73 | 2019 | |
| Becton, Dickinson and Company | $22.35 | 2025 | Bard X-Force Balloon Dilation Catheter |
| Profound Medical Corp. | $21.07 | 2025 | Tulsa-Pro |
| Foundation Medicine, INC. | $19.73 | 2021 | |
| Sun Pharmaceutical Industries INC. | $19.71 | 2019 | |
| Telix Pharmaceuticals | $18.47 | 2023 | Illuccix |
| Calyxo, INC. | $15.55 | 2024 | Cvac Aspiration System |
| Axonics, INC. | $14.89 | 2023 | Axonics |
| E.R. Squibb & Sons, L.L.C. | $14.02 | 2023 | Opdivo |
| Merck Sharp & Dohme LLC | $13.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Reyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.